Device Trial Radar · NCT05094401
Use of an Investigational Digital Therapeutic in Patients With Type 2 Diabetes
Last checked: Nov 19, 2026Latest source record: Sep 28, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
76
Actual
Start
Oct 4, 2021
Primary completion
Apr 1, 2023
Study completion Apr 1, 2023
Sponsor
- Lead sponsor
- Better TherapeuticsNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Catalyst Health Network
- First posted
- Oct 26, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
BT-001 is a software program intended to help patients with type 2 diabetes, under the guidance of their physician, improve glycemic control (i.e., levels of blood sugar). The BT-001 software delivers a type of behavioral therapy to patients via a mobile application that targets behaviors related to achieving glycemic control. The effectiveness of BT-001 will be measured by its ability to help patients reduce Hemoglobin A1c, or HbA1c (a marker in the blood that measures blood sugar) in patients with type 2 diabetes.
Conditions
- Type2 Diabetes
Interventions
BT-001Device
BT-001 is a software program intended to help patients with type 2 diabetes, under the guidance of their physician, improve glycemic control.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean change in HbA1cTime frame: Baseline and Day 365
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Catalyst Health Network
Plano, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.